Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
Biogen paid Ionis a US $ 60 million one-time upfront payment
Orencia is the first FDA-approved therapy to prevent acute graft versus host disease following hematopoietic stem cell transplant
This is the fourth facility from the company to receive this registration
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
The start-up has announced the scheme to mark World Diabetes Day
Subscribe To Our Newsletter & Stay Updated
